ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Array BioPharma is restructuring to reduce its spending rate and focus on its key clinical development programs, which are largely in the cancer area. The firm will reduce its workforce by about 20%, or 70 employees, primarily in discovery research and support jobs. It will still have a small discovery research group to handle late-stage projects and its partnerships with Amgen, Celgene, and Genentech.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X